User login

We offer our registered users tailored information, free online courses and exclusive content.

You have an old EXCEMED account ...

Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?

... or you lost your password?

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

A look at the European and US guidelines for the diagnosis and treatment of PKU

A look at the European and US guidelines for the diagnosis and treatment of PKU
  • Endocrinology and metabolism
  • Phenylketonuria (PKU)

EXCEMED’s PKU Academy interviewed Nicola Longo MD PhD, on his views on published guidelines for PKU, current challenges to treating patients with this life-long condition, and the difference to quality of life that the recent approval by the FDA of pegvaliase injection for adults with PKU will make.

Professor Longo is Professor of Pediatrics and adjunct Professor of Pathology at the University of Utah School of Medicine, USA, and has basic and clinical research interests in disorders of fatty acid oxidation and carnitine metabolism and the development of novel treatments for metabolic disorders including phenylketonuria, organic acidemias and lysosomal storage disorders.

Terms of use

This is a copyrighted resource for the sole purpose of education. Resource may be used for classroom training only and must remain as is, including the branding and EXCEMED logo. It is backed by a publishing license, signed by the author.